These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 7857294
1. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells. Beneytout JL, Nappez C, Leboutet MJ, Malinvaud G. Biochem Biophys Res Commun; 1995 Feb 06; 207(1):398-404. PubMed ID: 7857294 [Abstract] [Full Text] [Related]
2. Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells. Cailleteau C, Liagre B, Battu S, Jayat-Vignoles C, Beneytout JL. Anal Biochem; 2008 Sep 01; 380(1):26-34. PubMed ID: 18549804 [Abstract] [Full Text] [Related]
3. Megakaryocyte cell sorting from diosgenin-differentiated human erythroleukemia cells by sedimentation field-flow fractionation. Léger DY, Battu S, Liagre B, Beneytout JL, Cardot PJ. Anal Biochem; 2006 Aug 01; 355(1):19-28. PubMed ID: 16806034 [Abstract] [Full Text] [Related]
4. A proteomic approach to the identification of molecular targets in subsequent apoptosis of HEL cells after diosgenin-induced megakaryocytic differentiation. Cailleteau C, Liagre B, Beneytout JL. J Cell Biochem; 2009 Jul 01; 107(4):785-96. PubMed ID: 19415684 [Abstract] [Full Text] [Related]
5. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells. Cupit LD, Schmidt VA, Gnatenko DV, Bahou WF. Exp Hematol; 2004 Oct 01; 32(10):991-9. PubMed ID: 15504554 [Abstract] [Full Text] [Related]
6. Protein content and number of nucleolar organizer regions are enhanced during phorbol ester-induced differentiation of cultured human megakaryocytic cells. Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C. Anticancer Res; 1999 Oct 01; 19(4B):3229-35. PubMed ID: 10652616 [Abstract] [Full Text] [Related]
7. Role of MAPKs and NF-kappaB in diosgenin-induced megakaryocytic differentiation and subsequent apoptosis in HEL cells. Leger DY, Liagre B, Beneytout JL. Int J Oncol; 2006 Jan 01; 28(1):201-7. PubMed ID: 16327997 [Abstract] [Full Text] [Related]
8. Sonic Hedgehog activation is implicated in diosgenin-induced megakaryocytic differentiation of human erythroleukemia cells. Ghezali L, Liagre B, Limami Y, Beneytout JL, Leger DY. PLoS One; 2014 Jan 01; 9(4):e95016. PubMed ID: 24740159 [Abstract] [Full Text] [Related]
9. Expression of megakaryocytic and erythroid properties in human leukemic cells. Tani T, Ylänne J, Virtanen I. Exp Hematol; 1996 Feb 01; 24(2):158-68. PubMed ID: 8641337 [Abstract] [Full Text] [Related]
10. Changes in lipoxygenase activities in human erythroleukemia (HEL) cells during diosgenin-induced differentiation. Nappez C, Liagre B, Beneytout JL. Cancer Lett; 1995 Sep 04; 96(1):133-40. PubMed ID: 7553601 [Abstract] [Full Text] [Related]
11. Sustained c-kit expression in a human erythroleukemia cell line (HEL) after megakaryocytic differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). Bakić M, Ozawa K, Uemura N, Nishikawa M, Tojo A, Takahashi K, Tani K, Zaike Y, Ikebuchi K, Asano S. Leuk Res; 1993 Dec 04; 17(12):1079-82. PubMed ID: 7504152 [Abstract] [Full Text] [Related]
12. IL-3 and ribavirin induce high level expression of megakaryocytic markers and messages during long-term treatment of a megakaryocytic leukemia cell line. Majumdar A, Kerby S, Stenberg PE, Mullikin B, Beckstead JH, Cooney DA, Seidman MM. J Cell Physiol; 1994 Jul 04; 160(1):29-39. PubMed ID: 8021297 [Abstract] [Full Text] [Related]
13. Diosgenin dose-dependent apoptosis and differentiation induction in human erythroleukemia cell line and sedimentation field-flow fractionation monitoring. Léger DY, Liagre B, Cardot PJ, Beneytout JL, Battu S. Anal Biochem; 2004 Dec 15; 335(2):267-78. PubMed ID: 15556566 [Abstract] [Full Text] [Related]
14. Investigating the relationship between cell cycle stage and diosgenin-induced megakaryocytic differentiation of HEL cells using sedimentation field-flow fractionation. Cailleteau C, Micallef L, Lepage C, Cardot PJ, Beneytout JL, Liagre B, Battu S. Anal Bioanal Chem; 2010 Oct 15; 398(3):1273-83. PubMed ID: 20714892 [Abstract] [Full Text] [Related]
15. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells. Delgado MD, Quincoces AF, Gómez-Casares MT, Martínez CA, Cuadrado MA, Richard C, León J. Cancer Res; 1992 Nov 01; 52(21):5979-84. PubMed ID: 1394224 [Abstract] [Full Text] [Related]
16. Sedimentation field flow fractionation to study human erythroleukemia cell megakaryocytic differentiation after short period diosgenin induction. Léger DY, Battu S, Liagre B, Cardot PJ, Beneytout JL. J Chromatogr A; 2007 Jul 20; 1157(1-2):309-20. PubMed ID: 17499257 [Abstract] [Full Text] [Related]
17. Regulation of megakaryocyte phenotype in human erythroleukemia cells. Long MW, Heffner CH, Williams JL, Peters C, Prochownik EV. J Clin Invest; 1990 Apr 20; 85(4):1072-84. PubMed ID: 2318965 [Abstract] [Full Text] [Related]
18. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells. Fuchs R, Stelzer I, Haas HS, Leitinger G, Schauenstein K, Sadjak A. Ann Hematol; 2009 Oct 20; 88(10):989-97. PubMed ID: 19241077 [Abstract] [Full Text] [Related]
19. Expression and activation of protein kinase C isoforms in a human megakaryocytic cell line. Ballen KK, Ritchie AJ, Murphy C, Handin RI, Ewenstein BM. Exp Hematol; 1996 Nov 20; 24(13):1501-8. PubMed ID: 8950233 [Abstract] [Full Text] [Related]
20. Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells. Cellai C, Laurenzana A, Vannucchi AM, Della Malva N, Bianchi L, Paoletti F. FASEB J; 2002 May 20; 16(7):733-5. PubMed ID: 11923217 [Abstract] [Full Text] [Related] Page: [Next] [New Search]